FDA Approves Eli Lilly & Co.’s Obesity Drug ZepboundNovember 8, 2023 News The U.S. Food and Drug Administration (FDA) has granted approval for Eli Lilly & Co.’s obesity drug Zepbound, marking a…
FDA Approves Leqembi for Alzheimer’s TreatmentJuly 9, 2023 News The U.S. Food and Drug Administration (FDA) has granted full approval to Leqembi, an Alzheimer’s drug developed by Japanese pharmaceutical…